Lupus is never a simple disease, but it can be easy to overlook complicating factors that transform a straightforward presentation into something more complex and challenging. And few factors offer more potential for complexity and complication than fever and cytopenia. “Rheumatologists are often asked to…
A pair of sessions on Monday will offer attendees an update on new and evolving technologies that have the potential to help rheumatology health professionals manage and treat rheumatic disease and improve patient access to rheumatologic care. From 1:00 – 2:00 pm in Room 32…
All healthcare professionals who work in rheumatology had to start adapting to a new landscape of reporting and documentation on Jan. 1 of this year, when the Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act, or MACRA, began. As the changeover continues, the…
An ARHP session on Monday will offer attendees the latest information on new medications, new indications, safety issues, and FDA action on biosimilars over the past year. The session, Pharma Update: Safety, New Indications, Latest Approvals, will be held from 2:30 – 3:30 pm in…
Safety is a constant concern in treating rheumatologic diseases, and new data can impact the risk profile and use of accepted treatments from year to year. Monday’s FDA Update on Safety Issues in the Treatment of Rheumatic Diseasesession will provide the latest in safety of…
The practicing rheumatologist needs a basic understanding of the scientific principles that underlie autoimmune and inflammatory disorders. However, as both basic and clinical science knowledge grows, incorporating science material into undergraduate and graduate medical education is becoming increasingly more challenging. Spicing up Science Education: How…
Older adults, for whom mobility is critical to maintain independence, make up a significant percentage of the patients cared for by rheumatologists. Those who lose independence are less likely to remain in the community and have higher rates of morbidity, mortality, and self-care disability while…
It is increasingly recognized that changes in chondrocyte phenotypes play an active role in the response of cartilage to injury and in the pathogenesis of osteoarthritis (OA). The symposium Chondrocytes: To Live or Let Die? on Sunday will examine the role of chondrocytes in cartilage damage…
A panel will update attendees Monday on various bone-related disease issues, including current and investigational medications for treatment of osteoporosis, pediatric bone disease and its progression into adulthood, and osteonecrosis in patients with rheumatic disease. During Throw Me a Bone!: Update on Important Concepts in…
A session on Monday will explore the effect of rheumatoid arthritis (RA) disease activity on cardiovascular disease (CVD) outcomes in patients with RA. Joan M. Bathon, MD, Professor of Medicine and Chief of Rheumatology at Columbia University Medical Center in New York, will discuss the…